Tandem Diabetes Care | TNDM - Gewinn Vor Steuern

Aktienkurs
19.45
Täglich Wechseln
1.29 7.10%
Monatlich
1.46%
Jährlich
-2.65%
Q2 Prognose
19.92




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Eli Lilly USD 8.27B 1.03B 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
ICU Medical USD 70.3M 36.62M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Orthofix International USD -2.19M 20.07M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12